| |
| |
|
| Insider
Information: |
Shawver Laura |
| Relationship: |
Director |
| City: |
Cary |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
250,346 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$254,800 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
250,346 |
|
|
| Total
Value |
$254,800 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Synthorx, Inc. |
THOR |
President and CEO, Dir... |
2020-01-23 |
0 |
2020-01-23 |
0 |
Premium* |
|
|
Relay Therapeutics, Inc. |
RLAY |
Director |
2023-05-24 |
40,000 |
|
0 |
Premium* |
|
|
Silverback Therapeutics, Inc. |
SBTX |
Director |
2023-09-01 |
210,346 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SBTX |
Silverback Therapeutics, ... |
Director |
– • – |
2023-09-01 |
4 |
AS |
$7.71 |
$770,520 |
D/D |
(100,000) |
210,346 |
0 |
- |
|
| SBTX |
Silverback Therapeutics, ... |
Director |
– • – |
2023-09-01 |
4 |
OE |
$1.27 |
$127,000 |
D/D |
100,000 |
310,346 |
0 |
- |
|
| SBTX |
Silverback Therapeutics, ... |
Director |
– • – |
2023-08-04 |
4 |
AS |
$7.06 |
$133,471 |
D/D |
(18,897) |
210,346 |
0 |
- |
|
| SBTX |
Silverback Therapeutics, ... |
Director |
– • – |
2023-08-04 |
4 |
OE |
$1.27 |
$23,999 |
D/D |
18,897 |
229,243 |
0 |
- |
|
| SBTX |
Silverback Therapeutics, ... |
Director |
– • – |
2023-08-03 |
4 |
OE |
$1.27 |
$33,156 |
D/D |
26,107 |
236,453 |
0 |
- |
|
| SBTX |
Silverback Therapeutics, ... |
Director |
– • – |
2023-08-03 |
4 |
AS |
$7.01 |
$183,018 |
D/D |
(26,107) |
210,346 |
0 |
- |
|
| SBTX |
Silverback Therapeutics, ... |
Director |
– • – |
2023-08-02 |
4 |
AS |
$7.09 |
$257,265 |
D/D |
(36,281) |
210,346 |
0 |
- |
|
| SBTX |
Silverback Therapeutics, ... |
Director |
– • – |
2023-08-02 |
4 |
OE |
$1.27 |
$46,077 |
D/D |
36,281 |
246,627 |
0 |
- |
|
| SBTX |
Silverback Therapeutics, ... |
Director |
– • – |
2023-08-01 |
4 |
AS |
$7.19 |
$134,576 |
D/D |
(18,715) |
210,346 |
0 |
- |
|
| SBTX |
Silverback Therapeutics, ... |
Director |
– • – |
2023-08-01 |
4 |
OE |
$1.27 |
$23,768 |
D/D |
18,715 |
229,061 |
0 |
- |
|
| SBTX |
Silverback Therapeutics, ... |
Director |
– • – |
2023-07-07 |
4 |
OE |
$1.27 |
$11,250 |
D/D |
8,858 |
219,204 |
0 |
- |
|
| SBTX |
Silverback Therapeutics, ... |
Director |
– • – |
2023-07-07 |
4 |
AS |
$6.36 |
$56,372 |
D/D |
(8,858) |
210,346 |
0 |
- |
|
| SBTX |
Silverback Therapeutics, ... |
Director |
– • – |
2023-07-06 |
4 |
AS |
$6.34 |
$212,554 |
D/D |
(33,510) |
210,346 |
0 |
- |
|
| SBTX |
Silverback Therapeutics, ... |
Director |
– • – |
2023-07-06 |
4 |
OE |
$1.27 |
$42,558 |
D/D |
33,510 |
243,856 |
0 |
- |
|
| SBTX |
Silverback Therapeutics, ... |
Director |
– • – |
2023-07-05 |
4 |
AS |
$6.41 |
$199,552 |
D/D |
(31,112) |
210,346 |
0 |
- |
|
| SBTX |
Silverback Therapeutics, ... |
Director |
– • – |
2023-07-05 |
4 |
OE |
$1.27 |
$39,512 |
D/D |
31,112 |
241,458 |
0 |
- |
|
| SBTX |
Silverback Therapeutics, ... |
Director |
– • – |
2023-07-03 |
4 |
AS |
$6.73 |
$178,347 |
D/D |
(26,520) |
210,346 |
0 |
- |
|
| SBTX |
Silverback Therapeutics, ... |
Director |
– • – |
2023-07-03 |
4 |
OE |
$1.27 |
$33,680 |
D/D |
26,520 |
236,866 |
0 |
- |
|
| SBTX |
Silverback Therapeutics, ... |
Director |
– • – |
2023-06-02 |
4 |
AS |
$6.95 |
$187,240 |
D/D |
(26,941) |
210,346 |
0 |
- |
|
| SBTX |
Silverback Therapeutics, ... |
Director |
– • – |
2023-06-02 |
4 |
OE |
$1.27 |
$34,215 |
D/D |
26,941 |
237,287 |
0 |
- |
|
| SBTX |
Silverback Therapeutics, ... |
Director |
– • – |
2023-06-01 |
4 |
AS |
$6.80 |
$496,801 |
D/D |
(73,059) |
210,346 |
0 |
- |
|
| SBTX |
Silverback Therapeutics, ... |
Director |
– • – |
2023-06-01 |
4 |
OE |
$1.27 |
$92,785 |
D/D |
73,059 |
283,405 |
0 |
- |
|
| RLAY |
Relay Therapeutics, Inc. |
Director |
– • – |
2023-05-24 |
4 |
GD |
$0.00 |
$0 |
D/D |
12,099 |
40,000 |
0 |
- |
|
| SBTX |
Silverback Therapeutics, ... |
Director |
– • – |
2023-05-09 |
4 |
AS |
$5.31 |
$227,799 |
D/D |
(42,900) |
210,346 |
0 |
- |
|
| SBTX |
Silverback Therapeutics, ... |
Director |
– • – |
2023-05-09 |
4 |
OE |
$1.27 |
$54,483 |
D/D |
42,900 |
253,246 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
